Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Exp Ther Med
2016 Jan 01;111:201-207. doi: 10.3892/etm.2015.2864.
Show Gene links
Show Anatomy links
Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature.
Lin LI
,
Xu CW
,
Zhang BO
,
Liu RR
,
Ge FJ
,
Zhao CH
,
Jia RU
,
Qin QH
,
Stojsic J
,
Wang Y
,
Xu JM
.
???displayArticle.abstract???
Primary lung enteric adenocarcinoma is a rare type of invasive lung carcinoma. Its morphology and immunohistochemistry are those of colorectal carcinoma, but there is no associated primary colorectal carcinoma. The present study describes the case of a 53-year-old female who presented with an irritating cough and a mass around the right sternoclavicular joint. Comprehensive evaluation revealed involvement of the mediastinum, lungs, right sternoclavicular joint and right kidney. Biopsies from the mediastinal and right sternoclavicular joint tumors showed features of adenocarcinoma. Immunohistochemistry was positive for cytokeratin (CK)20 and caudal type homeobox transcription factor 2, and negative for CK7, thyroid transcription factor-1 and napsin A. Genotypic analysis identified the expression of wild-type epidermal growth factor receptor, Kirsten rat sarcoma viral oncogene homolog, serine/threonine-protein kinase B-Raf and UDP-glucuronosyltransferase 1-1. There was no expression of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase and a moderate expression of excision repair cross-complementation group 1, ribonucleoside-diphosphate reductase large subunit and tubulin β-3 chain. A strong expression of thymidylate synthase and 677TC genotype expression of methylenetetrahydrofolate reductase was observed. Gastroscopy, enteroscopy, colorectal colonoscopy and positron emission tomography-computed tomography failed to find evidence of a gastrointestinal malignancy and primary lung enteric adenocarcinoma was diagnosed. The presence of multiple metastases did not permit curative surgery. The patient was treated with 3 monthly cycles of the XELOX chemotherapy regimen; the response was poor with progression of supraclavicular lesions. Treatment was switched to the TP regimen for 4 monthly cycles, which resulted in a significant reduction in the size of the lung lesions; however, the supraclavicular lesion responded poorly to the treatment. The patient then received 2 cycles of the FOLFIRI regimen; however, the lung and right supraclavicular lesions progressed, causing increased right upper limb pain. The pain was alleviated by palliative surgery. Following surgery, the DP regimen was employed. Follow-up of the patient remains ongoing. The present findings suggest that the early diagnosis and treatment of primary lung enteric adenocarcinoma is likely to improve patient outcome.
André,
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
1999, Pubmed
André,
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
1999,
Pubmed
Barbareschi,
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
2003,
Pubmed
Bepler,
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
2008,
Pubmed
Bonanno,
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
2013,
Pubmed
Chhieng,
Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
2001,
Pubmed
Hatanaka,
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7.
2011,
Pubmed
Ho,
Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.
1995,
Pubmed
Huang,
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer.
1998,
Pubmed
Inamura,
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
2005,
Pubmed
Lau,
Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
2004,
Pubmed
Li,
Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.
2009,
Pubmed
Lin,
Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review.
2013,
Pubmed
Maeda,
Pulmonary intestinal-type adenocarcinoma.
2008,
Pubmed
Min,
Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration.
2013,
Pubmed
Moran,
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
2014,
Pubmed
Nagasaka,
Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
2004,
Pubmed
Olaussen,
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
2006,
Pubmed
Ou,
Rare subtypes of adenocarcinoma of the lung.
2011,
Pubmed
Qureshi,
Enteric adenocarcinoma lung: a rare presentation in an Omani woman.
2013,
Pubmed
Remo,
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management.
2013,
Pubmed
Reynolds,
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.
2009,
Pubmed
Saltz,
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.
2000,
Pubmed
Satoh,
Cytology of pulmonary adenocarcinomas showing enteric differentiation.
2006,
Pubmed
Siegel,
Cancer statistics, 2014.
2014,
Pubmed
Stojsic,
Intestinal type of lung adenocarcinoma in younger adults.
2014,
Pubmed
Sullivan,
Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.
2008,
Pubmed
Travis,
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
2011,
Pubmed
Travis,
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
2013,
Pubmed
Tsao,
Primary pulmonary adenocarcinoma with enteric differentiation.
1991,
Pubmed
Ueno,
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
2003,
Pubmed
Wang,
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
2014,
Pubmed
Yousem,
Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.
2005,
Pubmed